| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/21/2013 | WO2013038739A1 LUNG CANCER MARKER COMPLEMENT C3dg MOLECULE, AND METHOD FOR ANALYZING LUNG CANCER MARKER |
| 03/21/2013 | WO2013038736A1 Multilayer test piece for assaying glycosylated hemoglobin and assay method using same |
| 03/21/2013 | WO2013038735A1 Multilayer test piece for assaying glycosylated hemoglobin and assay method using same |
| 03/21/2013 | WO2013038696A1 Molecular marker for early indentification of pleural mesothelioma patients, and expression analysis method for same |
| 03/21/2013 | WO2013038691A1 Biological information detection sensor supply device |
| 03/21/2013 | WO2013038666A1 Light-induced seizure model in rat brains |
| 03/21/2013 | WO2013038412A2 Antibodies directed against signal peptides, methods and uses thereof |
| 03/21/2013 | WO2013038371A1 Means and methods for assessing gonadal toxicity |
| 03/21/2013 | WO2013038369A1 Means and methods for assessing kidney toxicity |
| 03/21/2013 | WO2013038341A1 Means and methods for assessing hematopoietic toxicity |
| 03/21/2013 | WO2013038331A1 System and method for the detection of abnormalities in a biological sample |
| 03/21/2013 | WO2013038306A1 System and kit for preparing a cytological sample for examination |
| 03/21/2013 | WO2013038158A1 Intracellular cell selection |
| 03/21/2013 | WO2013038139A1 A method of creating flavour combinations and flavoured products |
| 03/21/2013 | WO2013038127A1 Diagnostic apparatus |
| 03/21/2013 | WO2013038113A1 Method for determining the glycosylation of an antibody |
| 03/21/2013 | WO2013038016A2 Monoclonal antibodies for detection of high-risk human papillomavirus oncoprotein e7 |
| 03/21/2013 | WO2013038014A1 Method for diagnosing alzheimer's disease |
| 03/21/2013 | WO2013037972A1 Method for predicting response to endocrine therapy |
| 03/21/2013 | WO2013037970A1 Methods for monitoring responsiveness to anti-smad7 therapy |
| 03/21/2013 | WO2013037969A1 Test tape cassette and analytical test tape therefor |
| 03/21/2013 | WO2013037931A1 Device and method for controlling and regulating a paper machine |
| 03/21/2013 | WO2013037888A1 Immunoassay for detecting antibiotics |
| 03/21/2013 | WO2013037887A1 Competitive immunoassay for the detection of antibiotics |
| 03/21/2013 | WO2013037886A1 Immunoassay for detecting antibiotics |
| 03/21/2013 | WO2013037885A1 Immunoassay for detecting antibiotics |
| 03/21/2013 | WO2013037878A1 An in-vitro process for the quick determination of the infection status of an infection with an influenza virus type |
| 03/21/2013 | WO2013037824A1 Endoglycosidase from streptococcus pyogenes and methods using it |
| 03/21/2013 | WO2013037813A1 Methods for prognosis of diffuse large b-cell lymphoma |
| 03/21/2013 | WO2013037789A1 Neuregulin-1-based prognosis and therapeutic stratification of colorectal cancer |
| 03/21/2013 | WO2013037727A1 B7-h6 therapeutically active monoclonal antibody against b7-h6 polypeptide |
| 03/21/2013 | WO2013037714A1 BIOMARKERS FOR BREAST TUMOURS FROM Hsp70-ASSOCIATED PEPTIDES |
| 03/21/2013 | WO2013037700A1 Human papilloma virus (hpv) e7 is a prognostic marker for prostate cancer |
| 03/21/2013 | WO2013037695A1 Antibodies against e7 protein of human papilloma virus (hpv) |
| 03/21/2013 | WO2013037674A1 Method and device for investigating the flow properties and the viscosity of heterogeneous liquid substances, particularly at temperatures of 1000°c and more |
| 03/21/2013 | WO2013037182A1 Online volatile organic compound analyzer and using method thereof |
| 03/21/2013 | WO2013037119A1 Device and method for erythrocyte morphology analysis |
| 03/21/2013 | WO2013037073A1 Dual opposing fiber brushing |
| 03/21/2013 | WO2013037066A1 Ocab-based tools for screening of therapeutic agents, treating and diagnosing heart disease associated with cardiac remodeling |
| 03/21/2013 | WO2013037046A1 Method and system for amplification of nucleic acids in microfluidic volume hydrogels |
| 03/21/2013 | WO2013022262A9 Human resistin receptor, and use thereof |
| 03/21/2013 | WO2013016280A3 Compositions and methods for selecting aptamers |
| 03/21/2013 | WO2013014244A8 Nik inhibitors cell-based screening assay |
| 03/21/2013 | WO2013013066A3 Methods for assessing genomic instabilities in tumors |
| 03/21/2013 | WO2013010181A3 Methods of diagnosing cancer using epigenetic biomarkers |
| 03/21/2013 | WO2013009705A3 Biomarkers, methods, and compositions for inhibiting a multi-cancer mesenchymal transition mechanism |
| 03/21/2013 | WO2013009703A3 Antibodies, kit and method for detecting amyloid beta oligomers |
| 03/21/2013 | WO2012174232A3 Methods of identifying original and counterfeit articles using micro x-ray diffraction mapping |
| 03/21/2013 | WO2012167028A9 Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition |
| 03/21/2013 | WO2012166630A3 In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes |
| 03/21/2013 | WO2012164008A9 Method of evaluation of the effect of nanoparticles on cell cultures |
| 03/21/2013 | WO2012162257A3 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers |
| 03/21/2013 | WO2012157979A3 Portable hypermulticolor imaging optical module and kinase inhibitory drug screening system based on microbead color coding |
| 03/21/2013 | WO2012154203A3 Filovirus fusion proteins and their uses |
| 03/21/2013 | WO2012153964A3 Method for providing information for the histological classification of non-small-cell lung carcinoma using lipid profiles |
| 03/21/2013 | WO2012151527A3 Conductive patterns and methods for making conductive patterns |
| 03/21/2013 | WO2012149222A3 Methylated coding and non-coding rna genes as diagnostic and therapeutic tools for human melanoma |
| 03/21/2013 | WO2012145535A3 Animal model of human cancer and methods of use |
| 03/21/2013 | WO2012144859A3 Method and apparatus for analyzing protein-protein interaction on single-molecule level within the cellular environment |
| 03/21/2013 | WO2012141844A3 Methods predicting risk of an adverse clinical outcome |
| 03/21/2013 | WO2012112685A3 Compositions and methods for diagnosing ovarian cancer |
| 03/21/2013 | WO2011048200A3 Micro-capillary system with an increased volume of blood |
| 03/21/2013 | WO2009071065A3 Device for measuring transport systems in membranes |
| 03/21/2013 | WO2004059279A8 High-sensitivity assays for pathogen detection using metal-enhanced fluorescence |
| 03/21/2013 | US20130074218 Method for optimising gene expression using synonymous codon optimisation |
| 03/21/2013 | US20130074201 Cancer-specific genetic rearrangements |
| 03/21/2013 | US20130073611 Anti-terrorism water quality monitoring system |
| 03/21/2013 | US20130073308 Methods of Detecting a Fragment of Neurosecretory Protein VGF for Diagnosing Alzheimer's Disease |
| 03/21/2013 | US20130072666 Antibody Complexes and Methods for Immunolabeling |
| 03/21/2013 | US20130072582 Methods for diagnosing and treating encephalitis or epilepsy |
| 03/21/2013 | US20130072581 Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM Assay |
| 03/21/2013 | US20130072580 Use of urinary ngal to diagnose sepsis in very low birth weight infants |
| 03/21/2013 | US20130072572 New Signaling Molecule Involved in Ultraviolet Damage to Skin |
| 03/21/2013 | US20130072542 Piscine reovirus diagnostic compositions |
| 03/21/2013 | US20130072522 Process for Making Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 03/21/2013 | US20130072441 Protease Inhibitors and Preventives or Remedies for Disease |
| 03/21/2013 | US20130072437 Neuregulin isoforms,neuregulin polypeptides and uses thereof |
| 03/21/2013 | US20130072435 Tribonectins |
| 03/21/2013 | US20130072429 Assays and methods using biomarkers |
| 03/21/2013 | US20130072426 Diagnostic methods for obesity and related disorders |
| 03/21/2013 | US20130072400 Method for the diagnosis/prognosis of colorectal cancer |
| 03/21/2013 | US20130072398 Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis |
| 03/21/2013 | US20130072397 Methods for the diagnosis and prognosis of a tumor using bcat1 protein |
| 03/21/2013 | US20130072395 Method for early detection of cancers |
| 03/21/2013 | US20130072392 Compositions, Kits, and Methods for Identification, Assessment, Prevention, and Therapy of Cancer |
| 03/21/2013 | US20130072389 Theranostic and diagnostic methods using sparc and hsp90 |
| 03/21/2013 | US20130071953 Gdf-15 based means and methods for survival and recovery prediction in acute inflammation |
| 03/21/2013 | US20130071952 Luminescent polymer cyclic amplification |
| 03/21/2013 | US20130071951 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 03/21/2013 | US20130071950 Agglutination Based Sample Testing Device |
| 03/21/2013 | US20130071949 IMMUNOASSAY FOR QUANTIFICATION OF AN UNSTABLE ANTIGEN SELECTED FROM BNP AND proBNP |
| 03/21/2013 | US20130071947 Chirality sensor and method for detection of aflatoxin by using the sensor |
| 03/21/2013 | US20130071946 Suspension Container For Binding Particles For The Isolation Of Biological Material |
| 03/21/2013 | US20130071938 Method for analyzing sugar chain by mass spectrometry |
| 03/21/2013 | US20130071935 Dual Inlet Microchannel Device And Method For Using Same |
| 03/21/2013 | US20130071866 Method for testing the severtiy of an illness |
| 03/21/2013 | US20130071865 Devices And Methods For Detecting Amniotic Fluid In Vaginal Secretions |
| 03/21/2013 | US20130071864 Colorectal cancer marker vitronectin and method for analyzing vitronectin concentration in blood sample |
| 03/21/2013 | US20130071863 Sulfur-Containing Amino Acid Derivative |
| 03/21/2013 | US20130071862 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |